Proteostasis Therapeutics (PTI) IPO Opens Flat

Go back to Proteostasis Therapeutics (PTI) IPO Opens Flat

Proteostasis Therapeutics (PTI) Prices Upsized IPO at $8, Well Below Plan

February 11, 2016 8:26 AM EST

Proteostasis Therapeutics, Inc. (NYSE: PTI) announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. The company had planned to offer 3,850,000 shares at $12-$14. Shares are expected to... More